BIOMAT Database Logo BIOMAT Database Logo

Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients. 1994

S Nozaki, and T Ito, and W Kamiike, and F Uchikoshi, and S Yamamoto, and S Nakata, and R Shirakura, and M Miyata, and H Matsuda, and S M Stepkowski
First Department of Surgery, Osaka University Medical School, Japan.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007959 Lymphocyte Culture Test, Mixed Measure of histocompatibility at the HL-A locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way MLC test, the lymphocytes from one of the individuals are inactivated (usually by treatment with MITOMYCIN or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens. Leukocyte Culture Test, Mixed,Mixed Lymphocyte Culture Test,Mixed Lymphocyte Reaction,Mixed Leukocyte Culture Test,Mixed Leukocyte Reaction,Leukocyte Reaction, Mixed,Leukocyte Reactions, Mixed,Lymphocyte Reaction, Mixed,Lymphocyte Reactions, Mixed,Mixed Leukocyte Reactions,Mixed Lymphocyte Reactions
D008297 Male Males
D011915 Rats, Inbred BUF An inbred strain of rat that is used for cancer research, particularly the study of CARCINOGENESIS Rats, Inbred Buffalo,Rats, BUF,BUF Rat,BUF Rat, Inbred,BUF Rats,BUF Rats, Inbred,Buffalo Rats, Inbred,Inbred BUF Rat,Inbred BUF Rats,Inbred Buffalo Rats,Rat, BUF,Rat, Inbred BUF
D011917 Rats, Inbred Lew An inbred strain of rat that is used in BIOMEDICAL RESEARCH. Rats, Inbred Lewis,Rats, Lew,Inbred Lew Rat,Inbred Lew Rats,Inbred Lewis Rats,Lew Rat,Lew Rat, Inbred,Lew Rats,Lew Rats, Inbred,Lewis Rats, Inbred,Rat, Inbred Lew,Rat, Lew
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft

Related Publications

S Nozaki, and T Ito, and W Kamiike, and F Uchikoshi, and S Yamamoto, and S Nakata, and R Shirakura, and M Miyata, and H Matsuda, and S M Stepkowski
The prevention of accelerated cardiac allograft rejection in sensitized recipients after treatment with brequinar sodium.
October 1993, Transplantation,
S Nozaki, and T Ito, and W Kamiike, and F Uchikoshi, and S Yamamoto, and S Nakata, and R Shirakura, and M Miyata, and H Matsuda, and S M Stepkowski
A genetic survey of rat cardiac allograft rejection in presensitized recipients.
December 1976, Transplantation,
S Nozaki, and T Ito, and W Kamiike, and F Uchikoshi, and S Yamamoto, and S Nakata, and R Shirakura, and M Miyata, and H Matsuda, and S M Stepkowski
Use of brequinar sodium for preventing cardiac allograft rejection in primates.
June 1993, Transplantation proceedings,
S Nozaki, and T Ito, and W Kamiike, and F Uchikoshi, and S Yamamoto, and S Nakata, and R Shirakura, and M Miyata, and H Matsuda, and S M Stepkowski
Leflunomide abrogates accelerated heart allograft rejection in presensitized rats.
January 1997, Transplantation proceedings,
S Nozaki, and T Ito, and W Kamiike, and F Uchikoshi, and S Yamamoto, and S Nakata, and R Shirakura, and M Miyata, and H Matsuda, and S M Stepkowski
Accelerated cardiac allograft rejection in murine cytomegalovirus-infected C3H recipients.
February 1991, Transplantation proceedings,
S Nozaki, and T Ito, and W Kamiike, and F Uchikoshi, and S Yamamoto, and S Nakata, and R Shirakura, and M Miyata, and H Matsuda, and S M Stepkowski
Cardiac graft rejection in hypersensitized recipients: prevention of antibody response and graft rejection using brequinar sodium.
June 1993, Transplantation proceedings,
S Nozaki, and T Ito, and W Kamiike, and F Uchikoshi, and S Yamamoto, and S Nakata, and R Shirakura, and M Miyata, and H Matsuda, and S M Stepkowski
Cytidine potentiates the inhibitory effect of brequinar sodium on concordant cardiac xenograft rejection.
June 1994, Transplantation proceedings,
S Nozaki, and T Ito, and W Kamiike, and F Uchikoshi, and S Yamamoto, and S Nakata, and R Shirakura, and M Miyata, and H Matsuda, and S M Stepkowski
Malononitrilamides 715 and 279 prevent accelerated cardiac allograft rejection synergistically with cyclosporin A in presensitized rats.
June 1998, Transplant immunology,
S Nozaki, and T Ito, and W Kamiike, and F Uchikoshi, and S Yamamoto, and S Nakata, and R Shirakura, and M Miyata, and H Matsuda, and S M Stepkowski
Maturing thymocytes in accelerated rejection of cardiac allografts in presensitized rats.
September 1992, Transplantation,
S Nozaki, and T Ito, and W Kamiike, and F Uchikoshi, and S Yamamoto, and S Nakata, and R Shirakura, and M Miyata, and H Matsuda, and S M Stepkowski
Prevention of vascularized allograft and xenograft rejection in rodents by brequinar sodium.
June 1993, Transplantation proceedings,
Copied contents to your clipboard!